This cross-sectional study assesses whether synapses containing tau oligomers are excessively eliminated by microglia and astrocytes in brains of individuals with vs without dementia but similar neuropathologic changes at autopsy suggestive of early clinical stages of Alzheimer disease.
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | White Matter Hyperintensities in Alzheimer Disease | 0 | 6.14 | 01-12-2023 |
| 2 | p-Tau 217 and Aβ42/40 to Predict Early Brain Aβ Accumulation | 0 | 15.37 | 01-09-2024 |
| 3 | Blood Biomarkers to Detect Alzheimer Disease in Primary and Secondary Care | 0 | 5.63 | 15-10-2024 |
| 4 | Emerging Cerebrospinal Fluid Biomarkers of Disease Activity and Progression in Multiple Sclerosis | 0 | 8.77 | 01-04-2024 |
| 5 | Exploratory Tau Biomarker Results From a Study of BIIB080 in Alzheimer Disease | 0 | 10.76 | 01-12-2023 |
| 6 | Deferiprone in Alzheimer Disease | 0 | 10.42 | 01-01-2025 |
| 7 | Serum GFAP Dynamics, Disease Progression, and Therapy Response in MS | 0 | 8.04 | 03-08-2026 |
| 8 | Prognostic Value of Blood-Based P-Tau217 Levels for Progression to Cognitive Impairment | 0 | 14.88 | 14-07-2026 |
| 9 | Diagnostic Concordance Between Plasma p-Tau217 and Amyloid-β Biomarkers in Symptomatic Alzheimer's Disease: Evidence From a Chinese Cohort | 0 | 23.04 | 11-08-2026 |
| 10 | Why This Neurologist Says We've Been Looking at Alzheimer’s All Wrong | 0 | 21.9 | 29-07-2026 |